These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30872749)

  • 1. Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice.
    Jendryka M; Palchaudhuri M; Ursu D; van der Veen B; Liss B; Kätzel D; Nissen W; Pekcec A
    Sci Rep; 2019 Mar; 9(1):4522. PubMed ID: 30872749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clozapine-N-oxide and compound 21 on sleep in laboratory mice.
    Traut J; Mengual JP; Meijer EJ; McKillop LE; Alfonsa H; Hoerder-Suabedissen A; Song SH; Fehér KD; Riemann D; Molnar Z; Akerman CJ; Vyazovskiy VV; Krone LB
    Elife; 2023 Mar; 12():. PubMed ID: 36892930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G
    Marciante AB; Farmer GE; Cunningham JT
    J Neurophysiol; 2020 Aug; 124(2):591-609. PubMed ID: 32697679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A head-to-head comparison of two DREADD agonists for suppressing operant behavior in rats via VTA dopamine neuron inhibition.
    Lawson KA; Ruiz CM; Mahler SV
    Psychopharmacology (Berl); 2023 Oct; 240(10):2101-2110. PubMed ID: 37530882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemogenetic stimulation of the G
    Kim JH; Rahman MH; Lee WH; Suk K
    Pharmacol Res Perspect; 2021 Dec; 9(6):e00822. PubMed ID: 34676988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A head-to-head comparison of two DREADD agonists for suppressing operant behavior in rats via VTA dopamine neuron inhibition.
    Lawson KA; Ruiz CM; Mahler SV
    bioRxiv; 2023 Mar; ():. PubMed ID: 37034819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine N-oxide, compound 21, and JHU37160 do not influence effortful reward-seeking behavior in mice.
    Aomine Y; Oyama Y; Sakurai K; Macpherson T; Ozawa T; Hikida T
    Psychopharmacology (Berl); 2024 Jan; 241(1):89-96. PubMed ID: 37792024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated chemogenetic activation of dopaminergic neurons induces reversible changes in baseline and amphetamine-induced behaviors.
    Chohan MO; Fein H; Mirro S; O'Reilly KC; Veenstra-VanderWeele J
    Psychopharmacology (Berl); 2023 Dec; 240(12):2545-2560. PubMed ID: 37594501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys.
    Nagai Y; Miyakawa N; Takuwa H; Hori Y; Oyama K; Ji B; Takahashi M; Huang XP; Slocum ST; DiBerto JF; Xiong Y; Urushihata T; Hirabayashi T; Fujimoto A; Mimura K; English JG; Liu J; Inoue KI; Kumata K; Seki C; Ono M; Shimojo M; Zhang MR; Tomita Y; Nakahara J; Suhara T; Takada M; Higuchi M; Jin J; Roth BL; Minamimoto T
    Nat Neurosci; 2020 Sep; 23(9):1157-1167. PubMed ID: 32632286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local and Remote Chemogenetic Suppression of Hippocampal Seizures in Rats.
    Li D; Yan X; Xing Y; Yan J; Wang J; Zhang H; Wang J; Li X; Su Z; Loh HH; Yang X; Chen X
    Curr Neuropharmacol; 2024; 22(13):2240-2255. PubMed ID: 38333970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three DREADD agonists acting on Gq-DREADDs in the ventral tegmental area to alter locomotor activity in tyrosine hydroxylase:Cre male and female rats.
    Robinson HL; Nicholson KL; Shelton KL; Hamilton PJ; Banks ML
    Behav Brain Res; 2023 Oct; 455():114674. PubMed ID: 37722510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-potency ligands for DREADD imaging and activation in rodents and monkeys.
    Bonaventura J; Eldridge MAG; Hu F; Gomez JL; Sanchez-Soto M; Abramyan AM; Lam S; Boehm MA; Ruiz C; Farrell MR; Moreno A; Galal Faress IM; Andersen N; Lin JY; Moaddel R; Morris PJ; Shi L; Sibley DR; Mahler SV; Nabavi S; Pomper MG; Bonci A; Horti AG; Richmond BJ; Michaelides M
    Nat Commun; 2019 Oct; 10(1):4627. PubMed ID: 31604917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of DREADD agonists and administration route in a murine model of sleep enhancement.
    Ferrari LL; Ogbeide-Latario OE; Gompf HS; Anaclet C
    J Neurosci Methods; 2022 Oct; 380():109679. PubMed ID: 35914577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Chemogenetic Stimulation of the Nucleus Accumbens Produces Lasting Reductions in Binge Drinking and Ameliorates Alcohol-Related Morphological and Transcriptional Changes.
    Pozhidayeva DY; Farris SP; Goeke CM; Firsick EJ; Townsley KG; Guizzetti M; Ozburn AR
    Brain Sci; 2020 Feb; 10(2):. PubMed ID: 32085427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and slice electrophysiological assessment of DREADD ligand, deschloroclozapine (DCZ) in rats.
    Nentwig TB; Obray JD; Vaughan DT; Chandler LJ
    Sci Rep; 2022 Apr; 12(1):6595. PubMed ID: 35449195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lemborexant on pharmacokinetics of clozapine: A potential drug-drug interaction mediated by time-dependent inhibition of CYP3A4.
    Watanabe K; Misaka S; Kanno-Nozaki K; Chiyoda T; Suzuki Y; Sato A; Suto T; Kuroda J; Shimomura K; Miura I; Yabe H
    Br J Clin Pharmacol; 2024 Jan; 90(1):354-359. PubMed ID: 37596710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis for selective activation of DREADD-based chemogenetics.
    Zhang S; Gumpper RH; Huang XP; Liu Y; Krumm BE; Cao C; Fay JF; Roth BL
    Nature; 2022 Dec; 612(7939):354-362. PubMed ID: 36450989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing Effects of Chronic Chemogenetic Neuronal Stimulation on Energy Balance by Indirect Calorimetry.
    Yu S; Münzberg H
    Bio Protoc; 2018 Apr; 8(8):. PubMed ID: 29951570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose administration of DREADD agonist JHU37160 produces increases in anxiety-like behavior in male rats.
    Van Savage J; Avegno EM
    Behav Brain Res; 2023 Aug; 452():114553. PubMed ID: 37352979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deschloroclozapine exhibits an exquisite agonistic effect at lower concentration compared to clozapine-N-oxide in hM3Dq expressing chemogenetically modified rats.
    Shimizu M; Yoshimura M; Baba K; Ikeda N; Nonaka Y; Maruyama T; Onaka T; Ueta Y
    Front Neurosci; 2023; 17():1301515. PubMed ID: 38099201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.